Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
https://www.linkedin.com/posts/brain-plus_cst-carehomes-dementia-activity-7404438807430942720-N2Kl?utm_source=share&utm_medium=member_android&rcm=ACoAAB5yFvMBGDwma3GIsqrlG98N5EDm84BK3K4
This shows that TLC Care, which is one of the best-rated and most recognized care home chains in the UK (often highlighted by CQC), is now actively using Ayla in their dementia care program.
This means:
Brain+ is now with a “tier-1 care group” (TLC has 20+ premium homes in the London region).
It is not a pilot project, but training and implementation, i.e., real rollout.
TLC's profile (focused on quality, CQC excellence, high-end segment) is precisely the type of reference customer that drives adoption across the entire sector.
In other words:
👉 Brain+ is now starting to “activate” its commercial partnerships, both on the NHS side and with the large private chains, just before the 2026 license cycle begins
All my posts are based on the FACT that the revenue in brain is insignificant and completely insufficient to keep the company running without your money and eternal subsidies so they can pay their bills.
And I don't need to prove anything, the management does it for me. Not just one but two downgrades in a row prove loud and clear that I am right, besides the wild share price drop being another proof that I have been right all along in my skepticism.
You can deliver dreams and hopes every single day, while the stock has dropped 99.9%. Where can one find even a single sign that you have been right about anything of significance?
You just babble on about big dreams mixed with childish hopes and romantic dreams.
At 09,28, 1300 units were traded at a price of 0,009, is it me who doesn't understand the game, isn't that about 13kr for a fee of 20-25kr, where does that make sense??
The company has an idea, revenue, and a potential chance for a breakthrough supported by smaller shareholders, who hope for the same!!! So hoist the sail and set the course, dear brain, and I'll bring the rum 😁
The optimists are certainly not losing faith - I myself have just become incredibly tired of reading the same thing over and over here every day - so as written before - I have gone on Christmas holiday from B+ and now expect an exciting 2026. Nothing but good news from B+ & Co has come out from their side. Over and Out and then we'll hear from each other on the other side O-Leif
But it's remarkable that you never get tired of the same airy hopes and dreams, especially when you never, as in never, get proof that there's really any substance to those claims. Merry Christmas.
Stupid question maybe, but fortunately I haven't spent much money here, but am still 85.87% down on the stock, so the loss is indisputable.
But what do people think will happen if the company's direction changes just a little? To be 99.94% down from max is, after all, absurdly extreme.
So can we 10x on a couple of good news items?
It's mostly because it's been ultra bombed. But I can see in the feed that there are actually optimists here, so it can easily go down further, if they give up.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset ja analyysit
Uutiset ja lehdistötiedotteet
Analyysit
4 joulu 11.46
∙
Lehdistötiedote
Brain+ Investor Update - November
21 marras 14.15
∙
Lehdistötiedote
Impala Nordic: Brain+ - Guidance cut as timing delays intensify
19 marras 11.24
∙
Lehdistötiedote
Brain+ A/S updates its financial guidance for 2025
6 marras 14.13
∙
Lehdistötiedote
Brain+ investor update — October
31 loka 07.00
∙
Lehdistötiedote
BRAIN+ UPDATES ITS COMMUNICATION POLICY AS THE COMPANY MOVES INTO A NEW COMMERCIALISATION PHASE
6 loka 06.20
∙
Lehdistötiedote
Brain+ appoints new Chief Financial Officer
24 syys 13.40
∙
Lehdistötiedote
Impala Nordic: Brain+ – First Ayla NHS pilot launch in UK primary care
24 syys 06.36
∙
Lehdistötiedote
Brain+ launches first Ayla NHS pilot with one of the UK’s largest primary care practices
16 syys 07.21
∙
Lehdistötiedote
Brain+ signs agreement with Agincare Homes – the fourth UK care home group to deploy effective dementia therapy with Ayla
15 syys 09.41
∙
Lehdistötiedote
The Chief Financial Officer to transition, replacement search has been initiated
4 syys 09.58
∙
Lehdistötiedote
Clinical pilot of Ayla based dementia therapy (CST) improves cognitive outcome by nearly 50% in care home residents
3 syys 10.00
∙
Lehdistötiedote
Impala Nordic: Brain+ - Report Comment: Strategy on track, revenue defers into 2026
2 syys 07.44
∙
Lehdistötiedote
Brain+ expands its agreement with Southcare Homes Group to deploy Ayla across the group
1 syys 06.41
∙
Lehdistötiedote
Brain+ invites investors and other stakeholders to a webinar for a presentation of its Half Year 2025 report
Brain+ A/S announces first day of trading in new shares following the TO 5 warrant exercise
18 kesä 09.22
∙
Lehdistötiedote
Brain+ A/S announces the outcome of its series TO 5 warrant exercise
10 kesä 07.58
∙
Lehdistötiedote
Brain+ A/S has received commitments to cover 100% of its TO 5 warrants, securing DKK 5.9 million in gross proceeds
6 kesä 14.56
∙
Lehdistötiedote
Invitation to investor webinar featuring Antony Hall: How new CST evidence and UK dementia care quality focus underscore the relevance and potential of Ayla
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Tuotteita joiden kohde-etuutena tämä arvopaperi
Sertifikaatit
2025 H1 -tulosraportti
98 päivää sitten48 min
Uutiset ja analyysit
Uutiset ja lehdistötiedotteet
Analyysit
4 joulu 11.46
∙
Lehdistötiedote
Brain+ Investor Update - November
21 marras 14.15
∙
Lehdistötiedote
Impala Nordic: Brain+ - Guidance cut as timing delays intensify
19 marras 11.24
∙
Lehdistötiedote
Brain+ A/S updates its financial guidance for 2025
6 marras 14.13
∙
Lehdistötiedote
Brain+ investor update — October
31 loka 07.00
∙
Lehdistötiedote
BRAIN+ UPDATES ITS COMMUNICATION POLICY AS THE COMPANY MOVES INTO A NEW COMMERCIALISATION PHASE
6 loka 06.20
∙
Lehdistötiedote
Brain+ appoints new Chief Financial Officer
24 syys 13.40
∙
Lehdistötiedote
Impala Nordic: Brain+ – First Ayla NHS pilot launch in UK primary care
24 syys 06.36
∙
Lehdistötiedote
Brain+ launches first Ayla NHS pilot with one of the UK’s largest primary care practices
16 syys 07.21
∙
Lehdistötiedote
Brain+ signs agreement with Agincare Homes – the fourth UK care home group to deploy effective dementia therapy with Ayla
15 syys 09.41
∙
Lehdistötiedote
The Chief Financial Officer to transition, replacement search has been initiated
4 syys 09.58
∙
Lehdistötiedote
Clinical pilot of Ayla based dementia therapy (CST) improves cognitive outcome by nearly 50% in care home residents
3 syys 10.00
∙
Lehdistötiedote
Impala Nordic: Brain+ - Report Comment: Strategy on track, revenue defers into 2026
2 syys 07.44
∙
Lehdistötiedote
Brain+ expands its agreement with Southcare Homes Group to deploy Ayla across the group
1 syys 06.41
∙
Lehdistötiedote
Brain+ invites investors and other stakeholders to a webinar for a presentation of its Half Year 2025 report
Brain+ A/S announces first day of trading in new shares following the TO 5 warrant exercise
18 kesä 09.22
∙
Lehdistötiedote
Brain+ A/S announces the outcome of its series TO 5 warrant exercise
10 kesä 07.58
∙
Lehdistötiedote
Brain+ A/S has received commitments to cover 100% of its TO 5 warrants, securing DKK 5.9 million in gross proceeds
6 kesä 14.56
∙
Lehdistötiedote
Invitation to investor webinar featuring Antony Hall: How new CST evidence and UK dementia care quality focus underscore the relevance and potential of Ayla
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
https://www.linkedin.com/posts/brain-plus_cst-carehomes-dementia-activity-7404438807430942720-N2Kl?utm_source=share&utm_medium=member_android&rcm=ACoAAB5yFvMBGDwma3GIsqrlG98N5EDm84BK3K4
This shows that TLC Care, which is one of the best-rated and most recognized care home chains in the UK (often highlighted by CQC), is now actively using Ayla in their dementia care program.
This means:
Brain+ is now with a “tier-1 care group” (TLC has 20+ premium homes in the London region).
It is not a pilot project, but training and implementation, i.e., real rollout.
TLC's profile (focused on quality, CQC excellence, high-end segment) is precisely the type of reference customer that drives adoption across the entire sector.
In other words:
👉 Brain+ is now starting to “activate” its commercial partnerships, both on the NHS side and with the large private chains, just before the 2026 license cycle begins
All my posts are based on the FACT that the revenue in brain is insignificant and completely insufficient to keep the company running without your money and eternal subsidies so they can pay their bills.
And I don't need to prove anything, the management does it for me. Not just one but two downgrades in a row prove loud and clear that I am right, besides the wild share price drop being another proof that I have been right all along in my skepticism.
You can deliver dreams and hopes every single day, while the stock has dropped 99.9%. Where can one find even a single sign that you have been right about anything of significance?
You just babble on about big dreams mixed with childish hopes and romantic dreams.
At 09,28, 1300 units were traded at a price of 0,009, is it me who doesn't understand the game, isn't that about 13kr for a fee of 20-25kr, where does that make sense??
The company has an idea, revenue, and a potential chance for a breakthrough supported by smaller shareholders, who hope for the same!!! So hoist the sail and set the course, dear brain, and I'll bring the rum 😁
The optimists are certainly not losing faith - I myself have just become incredibly tired of reading the same thing over and over here every day - so as written before - I have gone on Christmas holiday from B+ and now expect an exciting 2026. Nothing but good news from B+ & Co has come out from their side. Over and Out and then we'll hear from each other on the other side O-Leif
But it's remarkable that you never get tired of the same airy hopes and dreams, especially when you never, as in never, get proof that there's really any substance to those claims. Merry Christmas.
Stupid question maybe, but fortunately I haven't spent much money here, but am still 85.87% down on the stock, so the loss is indisputable.
But what do people think will happen if the company's direction changes just a little? To be 99.94% down from max is, after all, absurdly extreme.
So can we 10x on a couple of good news items?
It's mostly because it's been ultra bombed. But I can see in the feed that there are actually optimists here, so it can easily go down further, if they give up.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
First North Denmark
Määrä
Osto
0
0,00
Myynti
Määrä
0,00
0
Viimeisimmät kaupat
Aika
Hinta
Määrä
Ostaja
Myyjä
-
-
-
-
-
Ylin
-
VWAP
0,01
Alin
-
Vaihto ()
-
VWAP
0,01
Ylin
-
Alin
-
Vaihto ()
-
Tietoa osakekaupankäyntiin liittyvistä riskeistä
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Brain+ A/S announces first day of trading in new shares following the TO 5 warrant exercise
18 kesä 09.22
∙
Lehdistötiedote
Brain+ A/S announces the outcome of its series TO 5 warrant exercise
10 kesä 07.58
∙
Lehdistötiedote
Brain+ A/S has received commitments to cover 100% of its TO 5 warrants, securing DKK 5.9 million in gross proceeds
6 kesä 14.56
∙
Lehdistötiedote
Invitation to investor webinar featuring Antony Hall: How new CST evidence and UK dementia care quality focus underscore the relevance and potential of Ayla
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Näytä kaikki
Seuraava tapahtuma
Sijoittajakalenteri ei ole saatavilla
Menneet tapahtumat
2025 H1 -tulosraportti
4.9.
2024 H2 -tulosraportti
29.4.
2024 H1 -tulosraportti
3.9.2024
2023 H2 -tulosraportti
7.5.2024
2023 H1 -tulosraportti
1.9.2023
Datan lähde: Quartr
Tuotteita joiden kohde-etuutena tämä arvopaperi
Sertifikaatit
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
https://www.linkedin.com/posts/brain-plus_cst-carehomes-dementia-activity-7404438807430942720-N2Kl?utm_source=share&utm_medium=member_android&rcm=ACoAAB5yFvMBGDwma3GIsqrlG98N5EDm84BK3K4
This shows that TLC Care, which is one of the best-rated and most recognized care home chains in the UK (often highlighted by CQC), is now actively using Ayla in their dementia care program.
This means:
Brain+ is now with a “tier-1 care group” (TLC has 20+ premium homes in the London region).
It is not a pilot project, but training and implementation, i.e., real rollout.
TLC's profile (focused on quality, CQC excellence, high-end segment) is precisely the type of reference customer that drives adoption across the entire sector.
In other words:
👉 Brain+ is now starting to “activate” its commercial partnerships, both on the NHS side and with the large private chains, just before the 2026 license cycle begins
All my posts are based on the FACT that the revenue in brain is insignificant and completely insufficient to keep the company running without your money and eternal subsidies so they can pay their bills.
And I don't need to prove anything, the management does it for me. Not just one but two downgrades in a row prove loud and clear that I am right, besides the wild share price drop being another proof that I have been right all along in my skepticism.
You can deliver dreams and hopes every single day, while the stock has dropped 99.9%. Where can one find even a single sign that you have been right about anything of significance?
You just babble on about big dreams mixed with childish hopes and romantic dreams.
At 09,28, 1300 units were traded at a price of 0,009, is it me who doesn't understand the game, isn't that about 13kr for a fee of 20-25kr, where does that make sense??
The company has an idea, revenue, and a potential chance for a breakthrough supported by smaller shareholders, who hope for the same!!! So hoist the sail and set the course, dear brain, and I'll bring the rum 😁
The optimists are certainly not losing faith - I myself have just become incredibly tired of reading the same thing over and over here every day - so as written before - I have gone on Christmas holiday from B+ and now expect an exciting 2026. Nothing but good news from B+ & Co has come out from their side. Over and Out and then we'll hear from each other on the other side O-Leif
But it's remarkable that you never get tired of the same airy hopes and dreams, especially when you never, as in never, get proof that there's really any substance to those claims. Merry Christmas.
Stupid question maybe, but fortunately I haven't spent much money here, but am still 85.87% down on the stock, so the loss is indisputable.
But what do people think will happen if the company's direction changes just a little? To be 99.94% down from max is, after all, absurdly extreme.
So can we 10x on a couple of good news items?
It's mostly because it's been ultra bombed. But I can see in the feed that there are actually optimists here, so it can easily go down further, if they give up.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
First North Denmark
Määrä
Osto
0
0,00
Myynti
Määrä
0,00
0
Viimeisimmät kaupat
Aika
Hinta
Määrä
Ostaja
Myyjä
-
-
-
-
-
Ylin
-
VWAP
0,01
Alin
-
Vaihto ()
-
VWAP
0,01
Ylin
-
Alin
-
Vaihto ()
-
Tietoa osakekaupankäyntiin liittyvistä riskeistä
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.